Cardiovascular (CV) safety of indacaterol/glycopyrronium (IND/GLY) compared with salmeterol/fluticasone combination (SFC) in moderate-to-very severe COPD patients with prior exacerbations: The FLAME study

  • Nicolas Roche, Petter Olsson, Jørgen Vestbo, Angel FowlerTaylor, Tim Ayers, Chau Thach, Karyn Clerkin, Robert Fogel, Francesco Patalano, Donald Banerji
  • European Respiratory Journal, September 2016, European Respiratory Society (ERS)
  • DOI: 10.1183/13993003.congress-2016.pa311

The authors haven't yet claimed this publication.

Read Publication

In partnership with:

Link to European Respiratory Society (ERS) showcase